The feds could actually soften their stance a little when it comes to weed.

The Food and Drug Administration is reviewing the medical evidence surrounding the safety and effectiveness of marijuana, a process that could lead to the agency downgrading the drug's current status as a Schedule I drug, the most dangerous classification.

FDA Press Officer Jeff Ventura described the review process, which is being completed at the request of the Drug Enforcement Agency, to The Huffington Post.

"FDA conducts for Health and Human Services a scientific and medical analysis of the drug under consideration, which is currently ongoing," Ventura said. "HHS then recommends to DEA that the drug be placed in a given schedule. DEA considers HHS’ analysis, conducts its own assessment, and makes a final scheduling proposal in the form of a proposed rule."

The FDA could not confirm how long the review process would take.

Read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.